The World Boxing Council has updated on the status of Women’s WBC super-middleweight title-holder Alejandra Jimenez following an adverse finding.
After defeating Franchon Crews-Dezurn to become a two-weight world champion, Jimenez was initially praised for the achievement.
Dropping down from being a heavyweight, Jimenez certainly got herself in spectacular shape for a crack at the 168-pound crown.
But all has since gone sour as Jimenez tested positive in the wake of the triumph. Opponent Crews-Dezurn has been vocal in her criticism of the Mexican.
WBC chiefs opened the ‘B’ sample at the request of Jimenez but the same result came back.
A suspension handed down by the WBC has been kept in place, with a more permanent punishment to follow.
The WBC said: “An “A” Sample the Voluntary Anti-Doping Association (“VADA”) collected from Ms. Alejandra Jimenez on January 10, 2020, the day before her bout against Franchon Crews Dezurn for the World Boxing Council (“WBC”) Word Female Super Middleweight Championship, yielded an adverse analytical finding.
“The WBC honored Ms. Jimenez’s request to witness the opening of the “B” Sample container. It took place on February 19, 2020.
“Ms. Jimenez has been informed that the test of the sample in the “B” sample container confirmed the adverse analytical finding of the “A” sample.
“Accordingly, in light of the adverse analytical finding of the samples in the “A” and “B” sample containers and pending the outcome of the WBC’s investigation and adjudicatory process, the WBC is hereby maintaining its provisional suspension of the WBC’s recognition of Alejandra Jimenez as WBC Female Super Middleweight Champion.
“The WBC has notified Ms. Jimenez that, as part of the WBC CBP Results Management Procedure, it is affording her and her team the opportunity to present any available information and materials, and any exculpatory evidence they might deem appropriate.”
As a result, Crews-Dezurn’s promoters at Golden Boy want the result overturned and their former champion given her belt back as a consequence.